Fidelity International
TNDM icon

Fidelity International’s Tandem Diabetes Care TNDM Stock Holding History

Fidelity International’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-191,417
Closed -$3.57M – 1055
2025
Q2 		$3.57M Sell
191,417
-1,077
-0.6% -$21.3K ﹤0.01% 654
2025
Q1 		$3.69M Sell
192,494
-8,882
-4% -$260K ﹤0.01% 623
2024
Q4 		$7.25M Buy
201,376
+65,984
+49% +$2.23M 0.01% 559
2024
Q3 		$5.74M Sell
135,392
-230
-0.2% -$9.75K 0.01% 602
2024
Q2 		$5.46M Buy
+135,622
New +$5.66M 0.01% 594
2021
Q1 		– Sell
-139,573
Closed -$13.4M – 1105
2020
Q4 		$13.4M Buy
139,573
+36,916
+36% +$3.8M 0.02% 453
2020
Q3 		$11.7M Buy
+102,657
New +$10.8M 0.01% 463

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity International's TNDM Position: Q3 2025 in Review

Fidelity International sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 191,417 shares — an estimated $3.57M sold.

Fidelity International first reported a position in TNDM in Q3 2020 and held it in 7 quarters. The position peaked at $13.4M in Q4 2020. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Fidelity International reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Fidelity International sold 191,417 Tandem Diabetes Care shares in Q3 2025, an estimated $3.57M.
  • Fidelity International first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 7 quarters.
  • Fidelity International's Tandem Diabetes Care position peaked at $13.4M in Q4 2020.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.